Cargando…

Facial Weakness, Otalgia, and Hemifacial Spasm: A Novel Neurological Syndrome in a Case-Series of 3 Patients With Rheumatic Disease

Bell palsy occurs in different rheumatic diseases, causes hemifacial weakness, and targets the motor branch of the 7th cranial nerve. Severe, persistent, and refractory otalgia having features of neuropathic pain (ie, burning and allodynic) does not characteristically occur with Bell palsy. Whereas...

Descripción completa

Detalles Bibliográficos
Autor principal:	Birnbaum, Julius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	6900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616731/ https://www.ncbi.nlm.nih.gov/pubmed/26447997 http://dx.doi.org/10.1097/MD.0000000000001445

Ejemplares similares

Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature
por: Menezes, Rikitha, et al.
Publicado: (2015)

Electrophysiologic Investigation During Facial Motor Neuron Suppression in Patients With Hemifacial Spasm: Possible Pathophysiology of Hemifacial Spasm: A Pilot Study
por: Choi, Soo In, et al.
Publicado: (2013)

Multiple Sclerosis Presenting with Facial Twitching (Myokymia and Hemifacial Spasms)
por: Hertz, Risha, et al.
Publicado: (2017)

Post-Irradiation Facial Neuromyotonia/Myokymia: A Hemifacial Spasm Mimic
por: Swinnen, Bart E. K. S., et al.
Publicado: (2021)

Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis
por: Kan, Shun-Li, et al.
Publicado: (2016)

Intraoperative Monitoring of the Facial Nerve during Microvascular Decompression for Hemifacial Spasm
por: Jeon, Chiman, et al.
Publicado: (2023)

Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature
por: Borrell, Helena, et al.
Publicado: (2016)

A novel etanercept biosimilar Anbainuo plus methotrexate exhibits increased cost-effectiveness compared to conventional disease-modifying anti-rheumatic drugs in treating rheumatoid arthritis patients
por: Tian, Feng, et al.
Publicado: (2019)

Hemifacial Spasm and Neurovascular Compression
por: Lu, Alex Y., et al.
Publicado: (2014)

A Case of Hemifacial Spasm Caused by an Artery Passing Through the Facial Nerve
por: Oh, Chang Hyun, et al.
Publicado: (2015)

Favorable retention rates and safety of conventional anti-rheumatic drugs in older patients with rheumatoid arthritis
por: Alpay-Kanitez, Nilüfer, et al.
Publicado: (2020)

Epidermoid cyst causing hemifacial spasm epidermoid cyst in cerebellopontine angle presenting with hemifacial spasm
por: Alemdar, Murat
Publicado: (2012)

Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis
por: Franco, André Silva, et al.
Publicado: (2017)

Double Crush Syndrome as a Cause of Hemifacial Spasm
por: Guerrero, Jaime, et al.
Publicado: (2021)

Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases
por: Elnady, Basant M., et al.
Publicado: (2016)

Prevalence of fatigue functional and social impairment among patients with rheumatic diseases compared to patients without: A cross-sectional comparison
por: Almalag, Haya M., et al.
Publicado: (2023)

Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review
por: Garra, Wakar, et al.
Publicado: (2023)

Clinical efficacy of belimumab in central nervous system demyelinating syndromes with systemic lupus erythematosus: A case series
por: Liu, Ya, et al.
Publicado: (2023)

Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan
por: Hayashi, Nobuhide, et al.
Publicado: (2021)

Reversible hemifacial spasm due to neurocysticercosis
por: Razdan, Sushil, et al.
Publicado: (2009)

Botulinum toxin in hemifacial spasm: Revisited
por: Singh, Sukhbir
Publicado: (2013)

Advances in microvascular decompression for hemifacial spasm
por: Cui, Zhiqiang, et al.
Publicado: (2015)

Microvascular decompression in patients with hemifacial spasm
por: Niu, Xuegang, et al.
Publicado: (2019)

Endoscopic Microvascular Decompression for Hemifacial Spasm
por: Matmusaev, Maruf, et al.
Publicado: (2020)

Vestibular Impairment in Hemifacial Spasm Syndrome: A Case Report
por: Barona, Luz, et al.
Publicado: (2020)

Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry
por: Kim, Seong-Kyu, et al.
Publicado: (2020)

Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescribing for older adults among rheumatologists
por: Lee, Jiha, et al.
Publicado: (2021)

Humoral immune response against BNT162b2 mRNA COVID-19 vaccine in patients with rheumatic disease undergoing immunosuppressive therapy: A Japanese monocentric study
por: Sugihara, Koichi, et al.
Publicado: (2022)

Arthritis secondary to meningococcal disease: A case series of 7 patients
por: Masson-Behar, Vanina, et al.
Publicado: (2017)

Hyperglycemic hemifacial spasm: A case report
por: Chen, Yanxing, et al.
Publicado: (2021)

Clinical characteristics and treatment outcomes in Camurati–Engelmann disease: A case series
por: Kim, Yoon-Myung, et al.
Publicado: (2018)

Severe Hemifacial Spasm is a Predictor of Severe Indentation and Facial Palsy after Microdecompression Surgery
por: Na, Boo Suk, et al.
Publicado: (2018)

Hemifacial Spasm in Mucopolysaccharidosis Type VI (Maroteaux–Lamy Syndrome)
por: Karir, Aneesh, et al.
Publicado: (2018)

Efficacy of bosentan in patients with refractory thromboangiitis obliterans (Buerger disease): A case series and review of the literature
por: Narváez, Javier, et al.
Publicado: (2016)

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study
por: Hibi, Toshifumi, et al.
Publicado: (2016)

Revisiting the link between hypertension and hemifacial spasm
por: Leong, Jia-Li, et al.
Publicado: (2016)

CPAP Therapy Improves Intractable Hemifacial Spasm
por: Kasemsap, Narongrit, et al.
Publicado: (2015)

Effect of Hemifacial Spasm on Intraocular Pressure Measurement
por: Cicik, Erdogan, et al.
Publicado: (2018)

Structural and Functional Amygdala Abnormalities in Hemifacial Spasm
por: Xu, Hui, et al.
Publicado: (2019)

Reversible Hemifacial Spasm after Starting Escitalopram
por: Basheikh, Mazen Abdulrahaman
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r1l7vjo6pu0979g3nkm9eikluj